Axon price target raised to $360 from $355 at Baird

Baird raised the firm’s price target on Axon to $360 from $355 and keeps an Outperform rating on the shares. The firm said they reported another strong beat and raise for revenue and margins. RPO, a point of contention following Q1’s slight sequential decline, grew 41% YOY and returned to sequential growth.